Home
>
US Stocks
>
Alnylam Pharmaceuticals Inc
Alnylam Pharmaceuticals Inc
ALNY

Alnylam Pharmaceuticals Inc

$208.563.05%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
208.97
Today Low/High
207.6 / 210.12
52 Week Low/High
$119.29 / $209.73
P/E ratio
-26.8408
Market Cap
$23.8B

Company Details

Alnylam Pharmaceuticals Inc. is leading the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of people afflicted with rare genetic, cardio-metabolic, hepatic infectious, and central nervous system (CNS)/ocular diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach for the treatment of a wide range of severe and debilitating diseases. Founded in 2002, Alnylam is delivering on a bold vision to turn scientific possibility into reality, with a robust RNAi therapeutics platform. Alnylam's commercial RNAi therapeutic products are ONPATTRO® (patisiran), GIVLAARI® (givosiran), and OXLUMO™ (lumasiran) and Leqvio® (inclisiran) being developed and commercialized by Alnylam's partner Novartis. Alnylam has a deep pipeline of investigational medicines, including six product candidates that are in late-stage development. Alnylam is executing on its 'Alnylam P5x25' strategy to deliver transformative medicines in both rare and common diseases benefiting patients around the world through sustainable innovation and exceptional financial performance, resulting in a leading biotech profile. Alnylam is headquartered in Cambridge, MA.
Organisation
Alnylam Pharmaceuticals Inc
Headquaters
Cambridge, Massachusetts, US
Employees
1.45K
Industry
Health Technology
CEO
John Maraganore
Company Financials
  • Annual P&L
  • Quarterly P&L

Discover more

Frequently Asked Questions

What is Alnylam Pharmaceuticals Inc share price today

Can Indians buy Alnylam Pharmaceuticals Inc shares?

How can I buy Alnylam Pharmaceuticals Inc shares from India?

Can Fractional shares of Alnylam Pharmaceuticals Inc be purchased?

What are the documents required to start investing in Alnylam Pharmaceuticals Inc stocks?

We are a SEBI registered investement advisor